5α-reductase and 17β-hydroxysteriod dehydrogenase expression in epithelial cells from hyperplastic and malignant human prostate

International Journal of Cancer

Volumn 75, Issue 6, 1998, Pages 840-846

  Délos, Sylvie ^a   Carsol, Jean Louis ^a   Fina, Frederic ^a   Raynaud, Jean Pierre ^b   Martin, Pierre Marie ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIONE; ANDROSTANOLONE; ANDROSTENEDIONE; MATRIGEL; MESSENGER RNA; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE; 3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; COLLAGEN; HYDROXYSTEROID DEHYDROGENASE; LAMININ; PROTEOGLYCAN; RNA; TESTOSTERONE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTOSTERONE METABOLISM; ADENOCARCINOMA; CELL CULTURE; CULTURE MEDIUM; DRUG COMBINATION; ENZYMOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE; PROSTATE TUMOR;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; COLLAGEN; CULTURE MEDIA; DRUG COMBINATIONS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LAMININ; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEOGLYCANS; RNA, NEOPLASM; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE; TUMOR CELLS, CULTURED;

EID: 0031594679     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980316)75:6<840::AID-IJC5>3.0.CO;2-V     Document Type: Article

References (37)

1. ADAMSKI, J., NORMAND, T., LEENDERS, F., MONTÉ, D., BEGUE, A., STÉHELIN, D., JUNGBLUT, P.W. and DE LAUNOIT, Y., Molecular cloning of a novel, widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV. Biochem. J., 311, 437-443 (1995).
2. ANDERSSON, S., BERMAN, D.M., JENKINS, E.P. and RUSSELL, D.W., Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature (Lond.), 354, 159-161 (1991).
3. ANDERSSON, S. and RUSSELL, D.W., Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc. nat. Acad. Sci. (Wash.), 87, 3640-3644 (1990).
4. HERMAN, D.M. and RUSSELL, D.W., Cell-type-specific expression of rat steroid 5α-reductase isoxymes. Proc. nat. Acad. Sci. (Wash.), 90, 9359-9363 (1993).
5. BERTHAUT, I., PORTOIS, M.C., CUSSENOT, O. and MOWSZOWICZ, I., Human prostatic cells in culture: different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates. J. Steroid Biochem. mol. Biol., 58, 235-242 (1996).
6. BLOMQUIST, C.H., LINDEMANN, N.J. and HAKANSON, E.Y., 17β-Hydroxysteroid dehydrogenase activities of human placenta microsomes: kinetic evidence for two enzymes differing in substrate specificity. Arch. Biochem. Biophys., 239, 206-215 (1985).
7. BRUCHOVSKY, N., SADAR, M.D., AKAKURA, K., GOLDENBERG, S.L., MATSUOKA, K. and RENNIE, P.S., Characterisation of 5α-reductase gene expression in stroma and epithelium of human prostate. J. Steroid Biochem. mol. Biol., 59, 397-404 (1996).
8. CARSOL, J.L., MARTIN, P.M. and DE LAUNOIT, Y. Characterization of 17β-hydroxysteroid dehydrogenase activity and mRNA expression in human meningioma tumors. Neuroendocrinology, 60, 445-451 (1994).
9. CASTAGNETTA, L., GRANATA, O.M., POLITO, L., BLASI, L., CANNELLA, S. and CARRUBA, G., Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. J. Steroid Biochem. mol. Biol., 49, 351-357 (1994).
10. 14C]testosterone by subcellular fractions of human prostate. Biochem. J., 99, 610-616 (1966).
11. CHOMCZYNSKI, P. and SACCHI, N., Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroibrm extraction. Anal. Bioehem., 162, 156-159 (1987).
12. CHUNG, L.W.K., Fibroblasts are critical determinants in prostatic cancer grown and dissemination. Cancer Metastasis Rev., 10, 263-274 (1991).
13. CUSSENOT, O., TEILLAC, P., LE DUC, A., KETELS, F. and CALVO, F., Cell culture from normal, benign hyperplasia and neoplasic human prostate gland tissue. Ann. Urol., 23, 533-537 (1989).
14. DÉLOS, S., CARSOL, J.L., GHAZAROSSIAN, E., RAYNAUD, J.P. and MARTIN, P.M., Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J. Steroid Biochem. Mol. Biol., 55, 375-383 (1995).
15. DÉLOS, S., IEHLÉ, C. MARTIN, P.M. and RAYNAUD, J.P. Inhibition of the activity of 'basic' 5α-reductase (type 1) detected in DU145 cells and expressed in insect cells. J. Steroid Biochem. mol. Biol., 48, 347-352 (1994).
16. DESCOMPS, B., NICOLAS, J.C. and CRASTES DE PAULET, A., Isolement de la 17β-hydroxysteroide NAD oxydoreductase du placenta humain. Bull. Soc. Chim. Biol., 50, 1681-1693 (1968).
17. EICHELER, W., TUOHIMAA, P., VILJA, P. ADERMANN, K., FORSSMANN, W.G. and AUMULLER, G., Immunocytochemical localization of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target tissue. J. Histochem. Cytochem., 42, 667-675 (1994).
18. ELO, J.P., AKINON, L.A., POUTANEN, M., VIHKO, P., KYEPÖNEN, A.P., LUKKARINEN, O. and VIHKO, R., Characterization of 17β-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int. J. Cancer, 66, 37-41 (1996).
19. FEINBERG, A.P. and VOGELSTEIN, B., A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13 (1983).
20. GASTON, K. and FRIED, M., The isolation of transcription factors from λgt11 cDNA expression libraries: human steroid 5α-reductase 1 has sequence-specific DNA binding activity. Nucl. Acids Res., 20, 6297-6301 (1992).
21. GEISSLER, W.M., DAVIS, D.L., WU, L., BKADSHAW, K.D., PATEL, S., MENDONCA, B.B., ELLISTON, K.O., WILSON, J.D., RUSSELL, D.W. and ANDERSSON, S., Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature (Genet.), 7, 34-39 (1994).
22. HIRSCH, S.H., JONES, C.D., AUDIA, J.E., ANDERSSON, S., MCQUAID, L., STAMM, N.B., NEUBAUER, B.L., PENNINGTON, P. and TOOMEY, R.E., LY191704: a selective, nonsteroidal inhibitor of human steroid 5α-reductase type 1. Proc. nat. Acad. Sci. (Wash.), 90, 5277-5281 (1993).
23. JENKINS, E.P., ANDERSSON, S., IMPERATO-MCGINLEY, J., WILSON, J.D. and RUSSELL, D., Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. clin. Invent., 89, 293-300 (1992).
24. KAEFER, M., AUDIA, J.E., BRUCHOVSKY, N., GOODE, R.L., HSIAO, K.C., LEIBOVITCH, I.Y., KRUSHINSKI, J.H., LEE, C. STEIDLE, C.P., SUTKOWSKI, D.M. and NEUBAUER, B.L., Characterization of type I 5α-reductase activity in DU 145 human prostatic adenocarcinoma cells. J. Steroid Biochem mol. Biol., 58, 195-205 (1996).
25. LABRIE, F. SUGIMOTO, Y., LUL-THE, V., SIMARD, J., BACHVAROV, D., LEBLANC, G., DUROCHER, F. and PAQUET, N., Structure of human type II 5α-reductase gene. Endocrinology, 131, 1571-1573 (1992).
26. LE GOFF, J.M. and MARTIN, P.M., Totally automatic combined system comprising an HPLC apparatus and on-line radiodetector (Flo-one) for routine analysis of prostatic enzyme activities. Progr. HPLC, 3, 79-91 (1988).
27. LEVINE, A.C., WANG, J.P., REN, M., ELIASHVILI, E., RUSSELL, D.W. and KIRSCHENBAUM, A., Immunohistochemical localization of steroid 5α-reductase 2 in the human male fetal reproductive tract and adult prostate. J. clin. Endocrinol. Metabolism, 81, 384-389 (1996).
28. MARTEL, C., RHÉAUME, E., TAKAHASHI, M., TRUDEL, C., COUËT, J., LUU-THE, V., SIMARD, J. and LABRIE, F., Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid Biochem. mol. Biol., 41, 597-603 (1992).
29. MARTINI, L., CELOTTI, S., LECHUGA, M.J., MELCANGI, R.C., MOTTA, M., NEGRI-CESI, P., POLETTI, A. and ZOPPI, S., Androgen metabolism in different target tissues. In: L. Castagnetta, S. d'Aquino, F. Labrie, and H.L. Bradlow (eds.), Steroid formation, degradation and action in peripheral tissues, pp. 184-198, Ann. N. Y. Acad. Sci., New York (1990).
30. ORLOWSKI, J, and CLARK, A.F., Epithelial-stromal interactions in the regulation of rat ventral prostate function: identification and characterization of pathways for androgen metabolism in isolated cell types. Endocrinology, 128, 872-884 (1991).
31. PASSANITI, A., ISAACS, J.T., HANEY, J.A., ADLER, S.W., CUJDIK, T.J., LONG, P.V. and KLEINMAN, H.K., Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int. J. Cancer, 51, 318-324 (1992).
32. SILVER, I., WILEY, E.L., THIGPEN, A.E., GUILEYARDO, J.M., MCCONNELL, J.D. and RUSSELL, D.W., Cell type specific expression of steroid 5α-reductase 2. J. Urol. 152, 438-442 (1994).
33. SMITH, C.M., BALLARD, S.A., WYLLIE, M.G. and MASTERS, J.R.W., Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro. J. Steroid Biochem. mol. Biol., 50, 151-159 (1994).
34. THIGPEN, A.E., SILVER, R.I., GUILEYARDO, J.M., CASEY, M.L., MCCONNELL, J.D. and RUSSELL. D.W., Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J. clin. Invest., 92, 903-910 (1993).
35. WILSON, J.D., GRIFFIN, J.E. and RUSSELL, D.W., Steroid 5α-reductase 2 deficiency. Endocr. Rev., 14, 577-593 (1993).
36. WU, L., EINSTEIN, M., GEISSLER, W.M., CHAN, H.K., ELLISTON, K.O. and ANDERSSON, S., Expression cloning and characterisation of human 17β-hydroxysteroid dehydrogenase type 2, a microsoma) enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J. biol. Chem., 268, 12964-12969 (1993).
37. YAMASAKI, H., Role of gap junctional intercellular communication in malignant cell transformation. In: E.L. Hertzberg and R.G. Johnson (eds.), Gap junctions, pp. 449-465. A.R. Liss, New York (1988).